Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUS3366975 A
Publication typeGrant
Publication dateFeb 6, 1968
Filing dateJun 4, 1965
Priority dateJun 4, 1965
Publication numberUS 3366975 A, US 3366975A, US-A-3366975, US3366975 A, US3366975A
InventorsWilliam J Pangman
Original AssigneeWilliam J. Pangman
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Compound prosthesis
US 3366975 A
Abstract  available in
Images(1)
Previous page
Next page
Claims  available in
Description  (OCR text may contain errors)

Feb. 6, 1968 1. PANGMAN COMPOUND PROSTHESIS Filed June 4, 1965 INVENTOR MAL/4M J @4A/@MN 3,366,975 Patented Feb. 6, 1968 3,366,975 CGMUND PROSTHESES William I. Pangman, 865 Comstock Ave. W., Los Angeles, Calif. 90024 Filed .lune 4, 1965, Ser. No. 461,326 9 Claims. (Cl. 3-36) ABSTRAQT @F THE DISCLOSURE A compound prosthesis for implanting in the human body has a core of a plastic foam, surrounded by a membrane impervious to uids and in turn covered by a porous layer to which human tissue can adhere. The core enables the device to retain a given shape, yet can approximate human tissue in density and rigidity to restore the body to its initial sham and appearance.

This invention relates generally to prostheses and, particularly, to an improved compound prosthesis to be implanted within the human body, particularly in the female breast, although the invention is not necessarily limited thereto.

Now it is a well-known practice in the field of plastic surgery to enlarge the female breast by prosthetic implants. In many other instances, it becomes necessary to remove the mammary glands or substantial portions of diseased body tissue in and around the glands, thus leaving voids which may be filled by prosthetic implants. Such implants provide physical support for the surrounding body tissue and organs and, in the case of voids near the skin, preserve the outward appearance of the body. When cancerous, precancerous, or damaged tissue is removed, it is often possible to insert the prosthesis to be implanted through the same surgical incision used for removing the tissue.

Particularly in the cases Where a radical removal of tissue has occurred is it desirable to use an implant for the purpose of restoring the human body to its original or natural form. The restoration of the normal appearance of the body has an extremely beneficial psychological effect on post-operative patients, eliminating much of the shock and depression that often follow extensive operations.

Among the various problems involved in prosthetic implants are those of preserving the natural softness and resiliency of the replaced body tissue and of retaining the implant in position in the body. The prosthesis employed preferably is soft and resilient in order to duplicate as nearly as possible the natural characteristics of the body tissue being replaced or built up. The use of prostheses having soft and resilient characteristics matching those of the replaced body tissues is particularly important in such cases as the female breast. In such cases, the desirability of retaining the implant iirmly in place is also obvious, both from the standpoint of appearance and also the comfort of the patient.

The desired degrees of softness and resiliency in a prosthetic implant have been met by the use of inert foamtype plastic sponge materials. Materials of this type are porous so that they absorb blood and other body iluids and become invaded by blood vessels and living body tissue. The result is that the sponge implant and the surrounding body tissue eventually become so interwoven as to be irmly united. This enables the implant to become anchored firmly to the chest Wall and also to the covering skin, thus becoming substantially a part of the body in the same manner as the replaced tissues.

The inherent porosity of such sponge materials, while very beneficial for the reason just mentioned, has also been the source of considerable inconvenience and disappointment after a time when a homogeneous, one-piece sponge implant is employed. The reason for this is that the sponge eventually becomes invaded by fibroblast tissue throughout all or a major portion of the implant. This type of connective tissue, being librous, shrinks as it ages, with the result that it compresses the implant and causes the implant to lose both its original size and shape and its original resiliency. Cases are known where shrinkage has been as much as 20-30%.

Other types of implants of a compound or composite construction may include a body of a liquid or liuid substance. Implants ot this character are often heavy and subject to an undesirable change in shape because of the ability of the lluid material to flow within the implant and accumulate at a low portion thereof. This change in shape is distressing and embarrassing to the wearer and is obviously undesirable.

Some types of compound prostheses have elements which are more or less discrete, being separable when in use. As a consequence, these prostheses are subject to the accumulation of fluid from the body in an interior void which can form between discrete elements of the prosthesis. In other cases, the possibility arises of extreme irritation of the body tissue after it has penetrated the prosthesis to a position where movement occurs between the discrete elements of the prosthesis that creates an irritation.

These conditions may become aggravated after a period of time to the point where it is necessary to surgically remove the old prosthesis and replace it with a new one. These prior constructions which make certain types of prostheses useful on only a short-term basis are obviously unsatisfactory.

Another shortcoming found to exist with some known prostheses is that they are not completely covered with a cellular layer which can become invaded by living tissue. Instead such a prosthesis has more or less of its external surface provided by an impervious material. Body fluid can, and often does, accumulate between the living tissue and such an impervious surface, causing distortion and, in severe cases, breakdown of tissue at the location of the wound.

Thus it is a general object of the present invention to provide a novel construction for a compound prosthesis so constructed that it is capable of being invaded by body tissue in order to unite it firmly to the body but not to such an extent that the connective tissue upon shrinking will materially change the size or shape of the implant.

It is also an object of the present invention to provide a novel construction for a compound prosthesis which is of unitary construction and provides no relatively movable or separable elements which provide a space in which liuid can accumulate or become a source of irritation to tissue of the patient.

A further object of the invention is to provide a compound prosthesis of the character described which has the qualities of softness and resiliency to the desired degree to resemble the tissue replaced, yet which is stable in shape and size so that it does not change size or shape with a change in position of the patient and also retains essentially the original size and shape over a long period of time.

These advantages are achieved. according to the present invention by providing a unitary compound prosthesis for implanting under the skin which comprises a resilient core of open-cell, foam-type plastic material having numerous pores extending throughout the core so that the core provides a light-Weight, resilient structuralskeleton; a barrier membrane surrounding and bonded to the core, said menibrane being substantially impervious to body cellular tissue in order to exclude said tissue from the core', and a covering external layer which is also a resilient, foam-type plastic having numerous pores throughout the external layer whereby it is pervious to and can become invaded by body cellular tissue to a limited depth, perhaps l to 2 millimeters.

ln one form of the invention, the cells of the core are filled with a resilient gel which is soft and yielding and thereby does not impair the resilient character of the core material but which is held in place by the structural network of the sponge material of the core. rl`his construction has a very low permeability to body fluids or cellular tissue and has a maximum potential of retaining its original size and shape. With this type of core, the barrier membrane may be entirely impervious to cellular tissue and body fiuids.

In another form of the invention, the cells'of the core may be left unfilled, becoming eventually filled with fluids from the body. In this embodiment, the cells of the core are preferably smaller than in the form previously mentioned. The barrier membrane is made of a material which is itself an impervious barrier to body fluids but which is preferably provided with a plurality of small openings through which fluids may pass to accumulate in the Core, such openings being so few in number and small in size that tissue is substantially excluded from the core.

How the above objects and advantages of the present invention, as well as others not specifically referred to, are attained will be better understood by reference to the following description and to the annexed drawing, in which:

FIG. 1 is a perspective view of a prosthesis shaped to replace a female breast, constructed in accordance with the present invention;

FIG. 2 is a vertical median section through the prosthesis of FIG. 1;

FIG. 3 is a greatly enlarged fragmentary view of the core with the pores inltrated with gel; and

FIG. 4 is an enlarged fragmentary section and elevation of a variational form of the invention.

Referring now to the drawing, there is shown a surgical prosthesis P for implanting under the skin of a human being constructed according to the present invention. From FIG. 2, it will be seen that the prosthesis comprises three principal parts, core itl, barrier membrane 11, and the external layer or covering 12. The shape of the prosthesis illustrated is solely for purposes of illustration and is not limitative upon the invention, since this prosthesis is one which is suitable for replacing substantially an entire breast, while others will differ in size and shape according to the specific requirements of the particular patient.

In general, a choice of materials is available to the manufacturer, subject to the requirement that the materials be ones which are compatible with each other and can be bonded together and also that the materials, particularly in the outer layer, are materials which are not rejected by the human body. Furthermore, the materials that are most satisfactory are those which are nonabsorbent and are, therefore, not subject to absorption of germs or bacteria but which, on the other hand, can be easily rendered sterile in an autoclave without damage to the prosthesis. Exemplary materials for the prosthesis will be mentioned, but are not necessarily limitative upon the invention.

Corey l() is preferably made of an open-cell polyurethane characterized by a degree of softness and resiliency closely comparable to the human tissue which it replaces. At the same time, the foam-type plastic sponge material is sufficiently strong to retain its original shape after implanting. A silicone sponge can be used but is not as strong as the polyurethane.

Open-cell polyurethane provides a porous structure in which there are numerous pores extending throughout the entire body of the core. These pores are preferably larger than the minimum size and may be characterized as large pores. In one embodiment of the invention, these pores lila are filled with a gel, as shown in FIG. 3 at 14, which is also soft and resilient so that it does not impair the overall resilient character of the composite core. The foam-type sponge material provides a struc` tural framework or stroma which gives physical strength and shape to the core and supports the small bodies of gel which fill the pores in the core. A core of this type in which the gel fills the pores is characterized by being substantially impervious to body fluids and body tissues.

The open-cell sponge is, usually, more rigid than the gel; and as a consequence, the firmness of the final product can be controlled within the desirable range by proper selection of pore size. A structure having large porcs is preferred as it gives the desired firmness while the gel filling the pores is softer or more yielding and so adds bulk without adding too much rigidity. Reduction in pore size increases the firmness of the sponge.

Completely surrounding core 10 and bonded thereto is the barrier membrane l1. This membrane is preferably made of a material which is impervious to fluids and also impervious to body tissues. Typical of such materials are various silicone polymers of medical grade.

The silicone material may be applied to the core in any suitable manner, as by wrapping the core in a sheet of silicone material which is then bonded to the core over substantially the entire area of the membrane and core in mutual contact, by the application of heat and light pressure. It is preferred to use a silicone of paste-like consistency that can be applied to the core over its entire exterior surface. The silicone is mixed with a room temperature vulcanizing agent, eliminating the need of heating in a mold to cure the silicone. The layer is preferably kept thin, typically about 1.0 millimeter or less and preferably about 0.5 millimeter. This thickness is adequate to be impervious but not thick enough to add undesired rigidity to the final product. Apart from the undesired rigidity, the membrane can be made thicker if de sired. Generally speaking, any material that provides a barrier impervious to body cellular tissue is satisfactory for the membrane, provided it is flexible and elastic to substantially the same degree as the core and is medically acceptable.

Surrounding the barrier membrane is a continuous external layer or covering 12 which is also an open-cell, foam-type sponge material. A suitable material for this purpose is a foamed polyether or a polyurethane which can be bonded to the core so that there is substantial adherence between the outer layer and the barrier member over their entire areas in mutual Contact.

The covering layer is preferably one which is characterized by small pores. The porosity of the outer layer is designed to permit it to become invaded by body cellular tissue, thereby causing the implant to adhere firmly to the wall of the chest and also to the covering skin and tissues. Thus the implant eventually becomes united with the surrounding tissues over substantially its entire exterior surface.

lt has been found advantageous to make the external layer 12 substantially uniform in thickness and relatively thin, it preferably being of the order of l or 2 millimeters in thickness, not more than about 2 millimeters being preferred. The advantage of this relatively thin external layer is that while it is thick enough to become thoroughly invaded by human tissue for anchoring the implant to the surrounding body, yet the total mass of the outer layer is also sufficiently small that the shrinkage of the fibroblast as the tissue ages and hardens has little effect in shrinking or changing the shape of the implant. Thus the small volume of the implant which can become invaded by tissue keeps the shrinkage Within acceptable limits.

In order to provide the necessary thin layer and keep the layer substantially uniform, the outer covering is preferably applied to the prosthesis in the form of a sheet of material which is shaped over the membrane-covered core and is bonded to the outer surface of the barrier membrane. Joints in the sheet material forming the outer layer are formed with abutting edges of the layer in contact so that they are bonded together and the outer layer is substantially continuous, although minor discontinuities in the outer layer do not interfere with satisfactory functioning of the prosthesis.

A convenient way of making the prosthesis is to apply the outer layer while the barrier membrane l1 is still plastic. The membrane as it cures then bonds to both the core and to the outer layer.

While the prosthesis constituting the present invention is not limited to any particular method of manufacture, it is preferred to cover the porous sponge material of the core with the barrier membrane before filling the pores of the sponge material with the gel. The core can then be impregna-ted with material in liquid form, using a hollow needle for this purpose. Air in the pores will be displaced by this liquid which forms the gel and can be withdrawn through another hollow needle. A suitable liquid material for this purpose is one of the elastomeric silicone polymers which has been compounded to produce the desired degree of elasticity in the gel produced. One such material is that prepared by Dow Corning as a solution with a 35036O centistoke viscosity. This silicone compound is mixed just prior to injection with a curing or vulcanizing agent which operates at room temperatures and is currently designated as a room temperature vulcanizing solution. A short time after injection into the core, the pores of the core are completely filled with the gel of a suitable degree of stiffness. The composite nature of the core is such that it remains soft and elastic, but the framework of the sponge-type material holds the gel against flowing or shifting its position with a change in position of the wearer, thus avoiding any change in shape of the completed prosthesis.

As a variation, the invention may be embodied in a prosthesis which is constructed as described except that the gel is omitted and the original pores of the foam-type material are left filled with air at the time of implantirig.

With this latter embodiment of the invention, illustrated in FIG. 4, the barrier membrane 11 is perforated in any suitable manner, as with a needle, to provide it with a plurality of small openings 15 which render the membrane pervious to a desired degree to body fluids. The body fluids then flow through these openings into the core, displacing the air therefrom and eventually filling the core with body fluids. Where it is apparent that this end result will be achieved or is desired, the surgeon will select this type of prosthesis with limited access of body fluids to the core.

Otherwise the form of the prosthesis just mentioned is constructed as illustrated and as previously described. The barrier membrane is preferably the same thickness as mentioned, typically about 0.5 millimeter, and the thin external layer 12 is fastened to the membrane in the same manner and has all the same characteristics already mentioned. The outer layer being pervious to body fluids, these body fluids can reach the small perforations in the membrane and pass through these perforations. While such perforations might allow body cellular tissue limited access to the core, yet they are so small and few in number that the amount of tissue which can reach and invade the core is negligible.

Both forms of the invention described provide a structure which is advantageous because all the elements of the prosthesis are rmly bonded together to form an integrated structure. This eliminates all voids Within the layers of the prosthesis which could either develop into spaces in which fluid from the body can accumulate or which could become invaded by tissue. When there is the capability of relative movement between portions of the prosthesis into which body tissue has entered, the movement causes irritation of the tissue that results both in the accumulation of fluid and in discomfort to the wearer Both conditions are avoided by the present invention since either one may eventually lead to the necessity for removal of a prosthesis.

In View of the foregoing description, it will be understood that various changes in the detailed construction may occur to persons skilled in the art Without departing from the spirit and scope of the present invention. For example, a larger size or sizes of the implant can be designed to fit within a chest cavity or other void Within the body. Accordingly, it is to be understood that the foregoing description is considered as being illustrative of, rather than limitative upon, the invention as defined by the appended claims.

I claim:

1. A unitary compound surgical prosthesis for implanting under the skin of a human being, comprising:

a resilient core of open-cell, foam-type plastic material having numerous pores extending throughout the core;

a barrier membrane surrounding and bonded to the core, said membrane being substantially impervious to body cellular tissue to exclude said tissue from the core;

and an external layer of a resilient, foam-type plastic having numerous pores throughout the external layer whereby the external layer is relatively pervious to body fluids and body cellular structure;

said external layer surrounding and being bonded to the barrier membrane.

2. A unitary compound surgical prosthesis as in claim 1 in which the thickness of the external layer is not more than about 2 millimeters.

3. A unitary compound surgical prosthesis as in claim 1 in which the pores of the core are substantially filled with a resilient gel excluding body fluids from the core but not impairing the resilient character of the core material.

4. A unitary compound surgical prosthesis as in claim 3 in which the barrier membrane is impervious to body fluids.

5. A unitary compound surgical prosthesis as in claim 1 in which the core and the barrier membrane are both pervious to body fluids.

6. A unitary compound surgical prosthesis as in claim 5 in which the barrier membrane is made of a non-porous material and has a plurality of minute perforations which pass body fluids.

7. A unitary compound surgical prosthesis as in claim 1 in which the barrier membrane has a plurality of minute perforations providing a controlled permeability to body fluids.

8. A unitary compound surgical prosthesis as in claim 1 in which the barrier membrane is not more than about 0.5 millimeter in thickness.

9. A unitary compound surgical prosthesis for implanting under the skin of a human being, comprising:

a resilient core of opencell, foam-type plastic material having numerous pores extending throughout the core, the pores of the core containing an elastic gel excluding body fluids from the core;

a barrier membrane not more than about 0.5 millimeter thick surrounding and bonded to the core, said mem- 7 8 brane being substantially impervious to body cellular References Cited tissue to exclude said tissue from the core; UNITED STATES PATENTS and an external layer not more than about 2 millimeters thick of a resilient, foam-type plastic having numer- 2,842,775 7/1958 Pangman 3-36 ous pores throughout the external layer whereby the 5 1g;

external layer is relatively pervious to body uids and body cellular structure, said external layer surrounding and being bonded t0 RICHARD A GAUDET Primary Examiner' the barrier membrane. R. FRINKS, Assistant Examiner.

Patent Citations
Cited PatentFiling datePublication dateApplicantTitle
US2842775 *Feb 23, 1954Jul 15, 1958Pangman William JCompound prosthesis device
US3189921 *Apr 11, 1962Jun 22, 1965Pangman William JCompound prosthesis
US3293663 *Aug 12, 1963Dec 27, 1966Dow CorningSurgically implantable human breast prosthesis
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US3548420 *Mar 6, 1967Dec 22, 1970Stryker CorpCushion structure
US3594796 *May 12, 1969Jul 20, 1971Int Standard Electric CorpDistance measuring
US3665520 *Oct 7, 1970May 30, 1972Medical Eng CorpSurgically implantable breast prosthesis
US3683424 *Jan 30, 1970Aug 15, 1972William J PangmanSurgically implantable compound breast prosthesis
US4298998 *Dec 8, 1980Nov 10, 1981Naficy Sadeque SBreast prosthesis with biologically absorbable outer container
US4380569 *Aug 3, 1981Apr 19, 1983Spenco Medical CorporationLightweight preformed stable gel structures and method of forming
US4455691 *Oct 3, 1979Jun 26, 1984Minnesota Mining And Manufacturing CompanySilicone gel filled prosthesis
US4472226 *Mar 18, 1982Sep 18, 1984Minnesota Mining And Manufacturing CompanySilicone gel filled prosthesis
US4507810 *Jan 29, 1982Apr 2, 1985Polar-Plastik HbImplantable breast prostheses
US4531244 *Jul 14, 1983Jul 30, 1985Hamas Robert SMammary prosthesis with multiple flow spaces
US4713073 *Dec 22, 1986Dec 15, 1987Reinmueller JohannesPlastic implant
US4740208 *Sep 27, 1985Apr 26, 1988Cavon Joseph FCast gel implantable prosthesis
US4773909 *Dec 9, 1986Sep 27, 1988Memorial Hospital For Cancer And Allied DiseasesMulti-lumen high profile mammary implant
US5007929 *Jul 27, 1990Apr 16, 1991Medical Products Development, Inc.Open-cell, silicone-elastomer medical implant
US5035716 *May 10, 1990Jul 30, 1991Downey Ernest LReplacement disc
US5092348 *Mar 28, 1990Mar 3, 1992Mcghan Medical CorporationTextured tissue expander
US5116370 *Mar 22, 1991May 26, 1992Foglietti Mark ABreast prosthesis with female and male adapter snaps
US5141581 *Aug 8, 1991Aug 25, 1992Markham Harold AImplants with a cover which resists formation of firm spherical encapsulation
US5147404 *Oct 24, 1990Sep 15, 1992Downey Ernest LVertebra prosthesis
US5158571 *Aug 21, 1991Oct 27, 1992Picha George JTissue expander and method for expanding tissue
US5271736 *Sep 25, 1992Dec 21, 1993Applied Medical ResearchCollagen disruptive morphology for implants
US5296069 *Jul 31, 1992Mar 22, 1994Silimed-Silicone E. Instrumental Medico Cirurgico E. Hosiptalar Ltda.Process for manufacturing implants having coated surfaces
US5376117 *Nov 13, 1992Dec 27, 1994Corvita CorporationBreast prostheses
US5383929 *Nov 27, 1991Jan 24, 1995Ledergerber; Walter J.Implantable prosthetic device
US5496370 *Jul 19, 1993Mar 5, 1996Robert S. HamasGel-like prosthetic device
US5525275 *Jul 27, 1993Jun 11, 1996Pmt CorporationMethod of manufacture of enhanced surface implant
US5564439 *Dec 27, 1994Oct 15, 1996George J. PichaInfusion device for soft tissue
US5658330 *Apr 25, 1995Aug 19, 1997Mcghan Medical Corp.Molded silicone foam implant and method for making
US5674285 *Dec 12, 1995Oct 7, 1997Medical Products Development, Inc.Mammary implant having shell with unitary rough-textured outer layer
US5706807 *Oct 11, 1996Jan 13, 1998Applied Medical ResearchSensor device covered with foam membrane
US5798065 *Oct 2, 1997Aug 25, 1998George J. PichaCollagen disruptive surface morphology for implants
US5824081 *Sep 13, 1996Oct 20, 1998Lipomatrix IncorporatedHydraulic foam tissue implant
US5935164 *Feb 25, 1997Aug 10, 1999Pmt CorporatonLaminated prosthesis and method of manufacture
US5961552 *Aug 2, 1997Oct 5, 1999Pmt CorporationInternally configured prosthesis
US5964803 *Apr 21, 1997Oct 12, 1999Pmt CorporationEnhanced surface implant and method of manufacture
US6146419 *Mar 3, 2000Nov 14, 2000Board Of Trustees Of The UniversityMethod for forming a hollow prosthesis
US6228116 *Mar 25, 1997May 8, 2001Walter J. LedergerberTissue expander
US6245960May 13, 1999Jun 12, 2001Board Of Trustees Of The University Of ArkansasInherent healing accelerator
US6283998May 13, 1999Sep 4, 2001Board Of Trustees Of The University Of ArkansasAlloplastic vertebral disk replacement
US6315796May 13, 1999Nov 13, 2001Board Of Trustees Of The University Of ArkansasFlexible seamless memory tissue expanding implant
US6419704Oct 8, 1999Jul 16, 2002Bret FerreeArtificial intervertebral disc replacement methods and apparatus
US6454804Oct 16, 2000Sep 24, 2002Bret A. FerreeEngineered tissue annulus fibrosis augmentation methods and apparatus
US6520989Jan 18, 2000Feb 18, 2003Board Of Trustees Of The University Of ArkansasExtreme volume flexible integrity prosthesis
US6605116Apr 3, 2001Aug 12, 2003Mentor CorporationReinforced radius mammary prostheses and soft tissue expanders
US6648919Jun 13, 2002Nov 18, 2003Bret A. FerreeTransplantation of engineered meniscus tissue to the intervertebral disc
US6648920Jun 13, 2002Nov 18, 2003Bret A. FerreeNatural and synthetic supplements to engineered annulus and disc tissues
US6755863Jun 13, 2002Jun 29, 2004Bret A. FerreeRotator cuff repair using engineered tissues
US6793677May 10, 2002Sep 21, 2004Bret A. FerreeMethod of providing cells and other biologic materials for transplantation
US6921418Mar 19, 2001Jul 26, 2005Walter J. LedergerberDual-sided, texturized biocompatible structure
US6969404Apr 11, 2002Nov 29, 2005Ferree Bret AAnnulus fibrosis augmentation methods and apparatus
US7060100Jul 16, 2004Jun 13, 2006Ferree Bret AArtificial disc and joint replacements with modular cushioning components
US7201774Apr 4, 2003Apr 10, 2007Ferree Bret AArtificial intervertebral disc replacements incorporating reinforced wall sections
US7201776Nov 25, 2002Apr 10, 2007Ferree Bret AArtificial intervertebral disc replacements with endplates
US7435260Jun 25, 2004Oct 14, 2008Ferree Bret AUse of morphogenetic proteins to treat human disc disease
US7641688Dec 22, 2005Jan 5, 2010Evera Medical, Inc.Tissue augmentation device
US7753954 *Apr 11, 2008Jul 13, 2010American Breast Care LPBreast prosthesis for patients with edema
US8202316Jan 28, 2009Jun 19, 2012Ledergerber Walter JModulating buttress saline mammary prosthesis
US8313527Oct 30, 2008Nov 20, 2012Allergan, Inc.Soft prosthesis shell texturing method
US8409280 *Sep 23, 2010Apr 2, 2013Amoena Medizin-Orthopaedie-Technik GmbhBreast prosthesis
US8419793 *Mar 12, 2010Apr 16, 2013Mentor Worldwide LlcCoating with antimicrobial agents
US8420153 *Sep 19, 2008Apr 16, 2013Mentor Worldwide LlcCoating with antimicrobial agents
US8487012Jan 25, 2011Jul 16, 2013Allergan, Inc.Open celled foams, implants including them and processes for making same
US8506627Aug 12, 2009Aug 13, 2013Allergan, Inc.Soft filled prosthesis shell with discrete fixation surfaces
US8545557 *Dec 31, 2007Oct 1, 2013Implite LtdHuman implantable tissue expander
US8546458Dec 7, 2011Oct 1, 2013Allergan, Inc.Process for texturing materials
US8679279Nov 15, 2011Mar 25, 2014Allergan, Inc.Methods for creating foam-like texture
US8679570Apr 25, 2011Mar 25, 2014Allergan, Inc.Foam-like materials and methods for producing same
US8685296May 10, 2011Apr 1, 2014Allergan, Inc.Porogen compositions, method of making and uses
US8801782Dec 15, 2011Aug 12, 2014Allergan, Inc.Surgical methods for breast reconstruction or augmentation
US8877822Sep 27, 2011Nov 4, 2014Allergan, Inc.Porogen compositions, methods of making and uses
US8889751Sep 28, 2011Nov 18, 2014Allergan, Inc.Porous materials, methods of making and uses
US8951596Jul 15, 2013Feb 10, 2015Allergan, Inc.Implants and methods for manufacturing same
US9044897Sep 28, 2011Jun 2, 2015Allergan, Inc.Porous materials, methods of making and uses
US9072821Feb 4, 2011Jul 7, 2015Allergan, Inc.Biocompatible structures and compositions
US9138308Aug 2, 2012Sep 22, 2015Apollo Endosurgery, Inc.Mucosal tissue adhesion via textured surface
US9138309Sep 24, 2012Sep 22, 2015Allergan, Inc.Porous materials, methods of making and uses
US9138310Oct 24, 2012Sep 22, 2015Allergan, Inc.Soft prosthesis shell texturing method
US9138311Jul 29, 2013Sep 22, 2015Allergan, Inc.Soft filled prosthesis shell with discrete fixation surfaces
US9155613Feb 6, 2014Oct 13, 2015Allergan, Inc.Methods for creating foam-like texture
US9205577Sep 28, 2012Dec 8, 2015Allergan, Inc.Porogen compositions, methods of making and uses
US9278158Aug 16, 2007Mar 8, 2016Peter ForsellMulti-material incontinence treatment construction device
US9333070Sep 30, 2013May 10, 2016Evera Medical, Inc.Breast implant with internal flow dampening
US9370414Oct 27, 2009Jun 21, 2016Implite Ltd.Reconstructive breast prostheses
US9393106May 8, 2014Jul 19, 2016Allergan, Inc.Soft filled prosthesis shell with discrete fixation surfaces
US9486308Nov 22, 2013Nov 8, 2016Allergan, Inc.Method of making a reinforced prosthetic implant with flexible shell
US20010010024 *Mar 19, 2001Jul 26, 2001Ledergerber Walter J.Tissue expander
US20020128630 *May 10, 2002Sep 12, 2002Ferree Bret A.Method and apparatus for providing nutrition to intervertebral disc tissue
US20020128718 *May 10, 2002Sep 12, 2002Ferree Bret A.Method of providing cells and other biologic materials for transplantation
US20020151981 *Jun 13, 2002Oct 17, 2002Ferree Bret A.Transplantation of engineered meniscus tissue to the intervertebral disc
US20020156532 *Jun 13, 2002Oct 24, 2002Ferree Bret A.Supplementing engineered annulus tissues with autograft or allograft tendons
US20020156533 *Jun 13, 2002Oct 24, 2002Ferree Bret A.Natural and synthetic supplements to engineered annulus and disc tissues
US20020165542 *Apr 11, 2002Nov 7, 2002Ferree Bret A.Annulus fibrosis augmentation methods and apparatus
US20030004574 *Aug 22, 2002Jan 2, 2003Ferree Bret A.Disc and annulus augmentation using biologic tissue
US20030026788 *Sep 24, 2002Feb 6, 2003Ferree Bret A.Use of extracellular matrix tissue to preserve cultured cell phenotype
US20030074076 *Nov 25, 2002Apr 17, 2003Ferree Bret A.Artificial intervertebral disc replacements with endplates
US20030191536 *Apr 4, 2003Oct 9, 2003Ferree Bret A.Artificial intervertebral disc replacements incorporating reinforced wall sections
US20040093092 *Jun 13, 2002May 13, 2004Ferree Bret A.Rotator cuff repair using engineered tissues
US20040172019 *Jul 9, 2002Sep 2, 2004Ferree Bret A.Reinforcers for artificial disc replacement methods and apparatus
US20040186573 *Feb 26, 2004Sep 23, 2004Ferree Bret A.Annulus fibrosis augmentation methods and apparatus
US20040230310 *Jun 25, 2004Nov 18, 2004Ferree Bret A.Use of morphogenic proteins to treat human disc disease
US20040260396 *Jul 16, 2004Dec 23, 2004Ferree Bret A.Artificial disc and joint replacements with modular cushioning components
US20060058891 *Sep 16, 2004Mar 16, 2006Lesh Michael DTransformable tissue bulking device
US20060161253 *Dec 22, 2005Jul 20, 2006Michael LeshTissue augmentation device
US20060235535 *Jun 12, 2006Oct 19, 2006Ferree Bret AArtificial disc and joint replacements with modular cushioning components
US20080215149 *Aug 30, 2007Sep 4, 2008Eun Hyun BaeLightweight Silicone Implant and Manufacturing Method Thereof
US20090118829 *Oct 30, 2008May 7, 2009Allergan, Inc.Soft prosthesis shell texturing method
US20090198329 *Feb 1, 2008Aug 6, 2009Kesten Randy JBreast implant with internal flow dampening
US20090216323 *Jan 28, 2009Aug 27, 2009Ledergerber Walter JModulating buttress saline mammary prosthesis
US20090255618 *Apr 11, 2008Oct 15, 2009American Breast CareBreast Prosthesis for Patients with Edema
US20100042211 *May 1, 2009Feb 18, 2010Allergan, Inc.Soft filled prosthesis shell with discrete fixation surfaces
US20100042212 *Aug 12, 2009Feb 18, 2010Allergan, Inc.Soft Filled Prosthesis Shell With Discrete Fixation Surfaces
US20100076113 *Sep 19, 2008Mar 25, 2010Mentor CorporationCoating with antimicrobial agents
US20100114312 *Dec 31, 2007May 6, 2010Implite LtdHuman implantable tissue expander
US20100198350 *Mar 12, 2010Aug 5, 2010Mentor Worldwide LlcCoating with antimicrobial agents
US20100292790 *May 12, 2010Nov 18, 2010Allergan, Inc.Implants and methods for manufacturing same
US20110046729 *Aug 9, 2010Feb 24, 2011Allergan, Inc.Reinforced Prosthetic Implant With Flexible Shell
US20110093069 *Oct 4, 2010Apr 21, 2011Allergan, Inc.Implants and methdos for manufacturing same
US20110117267 *Jan 21, 2011May 19, 2011Allergan, Inc.Soft Prosthesis Shell Texturing Method
US20110184531 *Jan 25, 2011Jul 28, 2011Allergan, Inc.Open celled foams, implants including them and processes for making same
US20110196488 *Jan 27, 2011Aug 11, 2011Allergan, Inc.Degradation resistant implantable materials and methods
US20110208302 *Oct 27, 2009Aug 25, 2011Implite Ltd.Reconstructive breast prostheses
US20110245921 *Sep 23, 2010Oct 6, 2011Amoena Medizin-Orthpaedie-Technik GmbHBreast Prosthesis
US20130096676 *Oct 12, 2012Apr 18, 2013Polytech Health & Aesthetics GmbhProcess for the manufacture of implants or intermediate products of such implants as well as implants and intermediate products obtained by such process
US20150150675 *Jan 16, 2015Jun 4, 2015Establishment Labs S.A.Implant with a visual indicator of a barrier layer
CN103040543A *Oct 11, 2012Apr 17, 2013波里泰克健康和美学股份有限公司Process for the manufacture of implants or intermediate products of such implants as well as implants and intermediate products obtained by such process
EP0030838A1 *Dec 9, 1980Jun 24, 1981Dow Corning CorporationSilicone gel-filled silicone rubber article possessing reduced surface-bleed
EP0125400A1 *Feb 22, 1984Nov 21, 1984EBERL, TertulinBreast prosthesis
EP0293256A1 *May 27, 1988Nov 30, 1988Mentor CorporationMethod of producing textured surface prosthesis implants
WO1981001650A1 *Nov 24, 1980Jun 25, 1981Dow CorningSilicone gel-filled silicone rubber article possessing reduced surface-bleed
WO1985000744A1 *Aug 16, 1984Feb 28, 1985Reinmueller JohannesSynthetic material implant
WO1986001997A1 *Sep 26, 1984Apr 10, 1986Tertulin EberlBreast prosthesis
WO2011062329A1Apr 12, 2010May 26, 2011Won-Seok YuArtificial breast implant having a surface formed into a silicon open cell foam layer, and method for manufacturing same
WO2014118773A1 *Jan 29, 2014Aug 7, 2014Implite Ltd.Human implantable tissue expanders
Classifications
U.S. Classification623/8, 128/DIG.210
International ClassificationA61F2/12
Cooperative ClassificationA61F2/12, Y10S128/21
European ClassificationA61F2/12
Legal Events
DateCodeEventDescription
Apr 16, 1984ASAssignment
Owner name: AMERICAN HEYER-SCHULTE CORPORATION
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST.;ASSIGNOR:HEYER-SCHULTE CORPORATION;REEL/FRAME:004245/0660
Effective date: 19800623
Apr 6, 1984AS02Assignment of assignor's interest
Owner name: AMERICAN HOSPITAL SUPPLY CORPORATION AN IL CORP
Owner name: MENTOR CORPORATION
Effective date: 19840330
Apr 6, 1984ASAssignment
Owner name: MENTOR CORPORATION
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST.;ASSIGNOR:AMERICAN HOSPITAL SUPPLY CORPORATION AN IL CORP;REEL/FRAME:004281/0957
Effective date: 19840330
Feb 22, 1983AS02Assignment of assignor's interest
Owner name: AMERICAN HEYER- SCHULTE CORPORATION
Effective date: 19830121
Owner name: AMERICAN HOSPITAL SUPPLY CORPORATION
Owner name: ONE AMERICAN PLAZA, EVANSTON, IL. 60201 A
Feb 22, 1983ASAssignment
Owner name: AMERICAN HOSPITAL SUPPLY CORPORATION; ONE AMERICAN
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST.;ASSIGNOR:AMERICAN HEYER- SCHULTE CORPORATION;REEL/FRAME:004099/0695
Effective date: 19830121